CUSIP: 42225K106
Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM CL A
-
Total 13F shares
-
12,097,651
-
Share change
-
-1,922,491
-
Total reported value
-
$301,551,395
-
Put/Call ratio
-
45%
-
Price per share
-
$24.93
-
Number of holders
-
116
-
Value change
-
-$50,110,305
-
Number of buys
-
53
-
Number of sells
-
62
Quarterly Holders Quick Answers
What is CUSIP 42225K106?
CUSIP 42225K106 identifies HIIQ - HEALTH INS INNOVATIONS INC - COM CL A in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2019
-
Previous quarter:
Q2 2019
Recent filing periods for CUSIP 42225K106:
Institutional Holders of HEALTH INS INNOVATIONS INC - COM CL A (HIIQ) as of Q3 2019
As of 30 Sep 2019,
HEALTH INS INNOVATIONS INC - COM CL A (HIIQ) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,097,651 shares.
The largest 10 holders included
CANNELL CAPITAL LLC, VANGUARD GROUP INC, P2 Capital Partners, LLC, BlackRock Inc., Atom Investors LP, River Road Asset Management, LLC, Nuveen Asset Management, LLC, CARDINAL CAPITAL MANAGEMENT LLC /CT, B. Riley Financial, Inc., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
116
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.